Want to join the conversation?
$FIS said its expects organic revenue growth of 3-4% in 2016. Adjusted EPS from continuing operations is expected to be $3.70-3.80, an increase of 15-18% compared to $3.22 per share in 2015. The company's free cash flow in 2016 is expected to approximate adjusted net earnings.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.